MORE ARTICLES
Mapping Mass Migration: New England State and County Population Change, 2020 to 2023January 21, 2025 - 1:48 pm
Stanford’s Lerone Martin on the Rev. Dr. Martin Luther King, Jr. & the Civil Rights MovementJanuary 17, 2025 - 11:13 am
Microschool First Impressions: Curious Mike & Spencer Blasdale Visit KaiPodJanuary 16, 2025 - 12:00 pm
McAnneny’s January Musings – Legislative Transparency Takes Center Stage in the New YearJanuary 15, 2025 - 1:55 pm
Pioneer Institute Statement on MBTA FundingJanuary 15, 2025 - 12:33 pm
ExcelinEd’s Dr. Kymyona Burk on Mississippi, Early Literacy, & Reading ScienceJanuary 15, 2025 - 11:42 am
Video Statement of Frank J. Bailey (Ret. Honorable), President of Pioneer Public Interest Law CenterJanuary 14, 2025 - 9:14 am
The House Call – JanuaryJanuary 13, 2025 - 1:25 pm
Mapping Mass Migration – Remote Workers: The Most Mobile ResidentsJanuary 9, 2025 - 2:18 pm
Statement on MBTA Communities Law Milton RulingJanuary 8, 2025 - 3:36 pm
The Realities Behind US Healthcare Spending
/in Blog: Healthcare, Featured, Healthcare, Life Sciences /by Gauri BinoyHealthcare policy is an all-encompassing term. It plays a role in every individual’s life; how it is curated, developed, and maintained has a significant long-term impact on the quality of life of any given community. It is critical that policymakers consistently adapt and amend healthcare policies in the ever-changing global pricing and affordability environment while providing funding support for optimal quality of care.
Cures for Patients, Not Health Plan Profits, Make Drugs Valuable
/in Featured, Life Sciences /by William SmithTo the astonishment of many observers, the Institute for Clinical and Economic Review (ICER) recently concluded that a $2.1 million gene therapy for a life-threatening blood disorder called beta thalassemia, is priced cost-effectively. The surprise was especially pleasant, given that ICER’s methodology had, in the past, displayed bias against rare disease treatments and undervalued the lives of people living with disabilities.
Khamzat Asabaev Wants to Put a Smile on Your Face
/in Economic Opportunity, Featured, JobMakers /by Editorial StaffThis week on JobMakers, host Denzil Mohammed talks with Khamzat Asabaev, refugee from Chechnya and cofounder of SoftSmile, a software tool that helps dentists provide affordable, quality orthodontic treatment. Khamzat pursued entrepreneurship to make basic services accessible to all, after experiencing a lack of access to basic care as a refugee and a minority. Refugees like Khamzat face terrible circumstances, but through resilience and fortitude, often make significant contributions to their adopted homeland, with higher rates of employment and entrepreneurship. That means they give back far more than we gave them, as you’ll discover in this week’s JobMakers.
School-Age Population Remains Steady, but Boston Struggles With Declining Enrollment
/0 Comments/in Academic Standards, Better Government, Blog, Blog: Better Government, Blog: Education, Blog: School Choice, Related Education Blogs, School Choice, Transparency /by Joseph StaruskiHopefully, new leadership will ensure that the system makes the changes necessary to improve public education in Boston. Otherwise, enrollment declines will continue.
Is a Universal Basic Income the Future? You Decide.
/in Blog: Transparency /by Etelson AlciusWith a rising cost of living, higher inflation, and an economy that generates fierce debates about inequality and poverty, many have called for systemic reforms and even more radical changes, including a universal basic income. What is UBI? How does it work? What do researchers think?